This Surgeon Preserved His Hand Function Thanks to New Amyloidosis Drug
sasint / Pixabay

This Surgeon Preserved His Hand Function Thanks to New Amyloidosis Drug

According to a story from the Irish Examiner, treatment with the recently approved drug patisiran helped a British surgeon named Carlos Heras-Palou save both his hands and his career. Patisiran…

Continue Reading This Surgeon Preserved His Hand Function Thanks to New Amyloidosis Drug

This Dad Climbed a Literal Mountain for His Daughter with Pompe Disease

The Malaysia Lysosomal Diseases Association (MLDA) was formed in 2011 by the hands of eight families. Their goal was to raise awareness and funds for those diagnosed with lysosomal storage…

Continue Reading This Dad Climbed a Literal Mountain for His Daughter with Pompe Disease
NZ Patient With Diffuse Large B Cell Lymphoma Fundraising to Travel to US For Treatment
Holgi / Pixabay

NZ Patient With Diffuse Large B Cell Lymphoma Fundraising to Travel to US For Treatment

According to a story from stuff.co.nz., Janelle Brunton-Rennie and Kurt Brunton were celebrating their third wedding anniversary this past January. Little did they know that the next day, their lives…

Continue Reading NZ Patient With Diffuse Large B Cell Lymphoma Fundraising to Travel to US For Treatment
Proof of Concept Data Released for Potential Primary Hyperoxaluria Treatment
jarmoluk / Pixabay

Proof of Concept Data Released for Potential Primary Hyperoxaluria Treatment

According to a story from BioPortfolio, the drug development company Dicerna Pharmaceuticals recently announced the release of proof of concept data in its Phase I trial testing the company's experimental…

Continue Reading Proof of Concept Data Released for Potential Primary Hyperoxaluria Treatment
BeiGene and Springworks Therapeutics are Collaborating to Research a Combination Therapy for Advanced Solid Tumours
stevepb / Pixabay

BeiGene and Springworks Therapeutics are Collaborating to Research a Combination Therapy for Advanced Solid Tumours

The companies BeiGene Ltd. and SpringWorks Therapeutics have announced that they will collaborate to research the safety and preliminary efficacy of a combination of two drugs: BeiGene’s investigational drug lifirafenib…

Continue Reading BeiGene and Springworks Therapeutics are Collaborating to Research a Combination Therapy for Advanced Solid Tumours
Multiple Studies Help Define New Biomarkers for Myelodysplastic Syndromes
luvqs / Pixabay

Multiple Studies Help Define New Biomarkers for Myelodysplastic Syndromes

According to a story from Medpage Today, three recent research studies have managed to reveal new biomarkers for myelodysplastic syndromes. Biomarkers are a crucial factor for understanding a medical condition…

Continue Reading Multiple Studies Help Define New Biomarkers for Myelodysplastic Syndromes
A Supplemental New Drug Application Has Been Submitted for a Potential Treatment of Immune Thrombocytopenia
jarmoluk / Pixabay

A Supplemental New Drug Application Has Been Submitted for a Potential Treatment of Immune Thrombocytopenia

Dova Pharmaceutics has submitted a supplemental New Drug Application to the US FDA on behalf of Doptelet® (avatrombopag), which is being researched as an investigational treatment of immune thrombocytopenia in…

Continue Reading A Supplemental New Drug Application Has Been Submitted for a Potential Treatment of Immune Thrombocytopenia

A Study of Huntington’s Disease in Mice Suggests an ‘Early Stage’ of the Condition

A recent study using mice suggests that Huntington’s disease may begin to show symptoms early on in life. For more detailed information, you can read the source article here, at…

Continue Reading A Study of Huntington’s Disease in Mice Suggests an ‘Early Stage’ of the Condition
Eiger and the FDA Have Met to Disucss Lonafarnib, an Investigational Treatment For Progeria
jniittymaa0 / Pixabay

Eiger and the FDA Have Met to Disucss Lonafarnib, an Investigational Treatment For Progeria

The US Food and Drug Administration and Eiger BioPharmaceuticals, Inc. have met to discuss lonafarnib, a drug being investigated as a potential treatment for Hutchinson-Gilford Progeria Syndrome. For more detailed…

Continue Reading Eiger and the FDA Have Met to Disucss Lonafarnib, an Investigational Treatment For Progeria